BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17879516)

  • 1. Interpreting the COURAGE trial. It takes COURAGE to alter our belief system.
    Boden WE
    Cleve Clin J Med; 2007 Sep; 74(9):623-5, 629-33. PubMed ID: 17879516
    [No Abstract]   [Full Text] [Related]  

  • 2. Interpreting the COURAGE trial. PCI is no better than medical therapy for stable angina? Seeing is not believing.
    Kereiakes DJ
    Cleve Clin J Med; 2007 Sep; 74(9):637-8, 640-2. PubMed ID: 17879517
    [No Abstract]   [Full Text] [Related]  

  • 3. Interpreting the COURAGE trial. Is medical therapy as good as PCI in stable angina? Two views.
    Bhatt DL
    Cleve Clin J Med; 2007 Sep; 74(9):618, 620. PubMed ID: 17879515
    [No Abstract]   [Full Text] [Related]  

  • 4. One year perspective on COURAGE.
    Tommaso CL
    Catheter Cardiovasc Interv; 2008 Sep; 72(3):426-429. PubMed ID: 18727125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current indications for percutaneous coronary intervention for chronic stable angina: implications of the COURAGE Trial.
    Kiernan TJ; Prasad A; Gersh BJ
    Rev Cardiovasc Med; 2007; 8(4):234-9. PubMed ID: 18192947
    [No Abstract]   [Full Text] [Related]  

  • 6. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.
    Borden WB; Redberg RF; Mushlin AI; Dai D; Kaltenbach LA; Spertus JA
    JAMA; 2011 May; 305(18):1882-9. PubMed ID: 21558519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS-II): prologue to COURAGE.
    King SB
    Circulation; 2007 Mar; 115(9):1064-6. PubMed ID: 17339563
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina.
    Latib A; Chieffo A; Colombo A
    Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):92-3. PubMed ID: 19065124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directional atherectomy, rotational atherectomy and coronary stent, followed by coronary bypass operation in a patient with the aggressive restenotic process.
    Cigarroa JE; Midha S; Jang IK
    Acta Cardiol; 1995; 50(6):469-75. PubMed ID: 8932567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics, treatment and outcome of patients with non-ST-elevation acute coronary syndromes and multivessel coronary artery disease: observations from PURSUIT (platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrelin therapy).
    Breeman A; Mercado N; Lenzen M; van den Brand MM; Harrington RA; Califf RM; Topol EJ; Simoons ML; Boersma E;
    Cardiology; 2002; 98(4):195-201. PubMed ID: 12566649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: One year perspective on COURAGE.
    Sedlis SP; Boden WE; Weintraub WS; Maron DS; O'Rourke RA; Berman DS; Mancini GB;
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):428. PubMed ID: 19133682
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM; Addo T
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of percutaneous revascularization in the treatment of ischemic heart disease: insights from published reports and randomized clinical trials.
    Levine GN; Ali MN
    Chest; 1997 Sep; 112(3):805-21. PubMed ID: 9315818
    [No Abstract]   [Full Text] [Related]  

  • 14. [Eptifibatide and percutaneous coronary intervention].
    Haude M
    Herz; 2004 Nov; 29(7):649-50. PubMed ID: 15580317
    [No Abstract]   [Full Text] [Related]  

  • 15. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
    Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
    J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital outcome of coronary artery bypass grafting and coronary endarterectomy.
    Abid AR; Farogh A; Naqshband MS; Akhtar RP; Khan JS
    Asian Cardiovasc Thorac Ann; 2009 Jan; 17(1):59-63. PubMed ID: 19515882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten years after: "I'd love to change the world".
    Tommaso CL
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):427. PubMed ID: 19681115
    [No Abstract]   [Full Text] [Related]  

  • 18. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.
    Cohen DJ; Van Hout B; Serruys PW; Mohr FW; Macaya C; den Heijer P; Vrakking MM; Wang K; Mahoney EM; Audi S; Leadley K; Dawkins KD; Kappetein AP;
    N Engl J Med; 2011 Mar; 364(11):1016-26. PubMed ID: 21410370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies.
    Yan TD; Padang R; Poh C; Cao C; Wilson MK; Bannon PG; Vallely MP
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1134-44. PubMed ID: 21167508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COURAGE to make choices. When it comes to treating angina or a narrowed coronary artery, angioplasty is no better than medical therapy for preventing heart attacks or premature death.
    Harv Heart Lett; 2007 Jun; 17(10):5. PubMed ID: 17654799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.